Literature DB >> 19159982

BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management.

Mingzhao Xing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19159982      PMCID： PMC2692039          DOI： 10.1245/s10434-008-0298-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  22 in total

1.  Managing small thyroid cancers.

Authors:  Ernest L Mazzaferri
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

2.  Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.

Authors:  C Cappelli; M Castellano; M Braga; E Gandossi; I Pirola; E De Martino; B Agosti; E Agabiti Rosei
Journal:  J Surg Oncol       Date:  2007-06-01       Impact factor: 3.454

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

Review 4.  Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.

Authors:  Laurence Leenhardt; Pascale Grosclaude; Laurence Chérié-Challine
Journal:  Thyroid       Date:  2004-12       Impact factor: 6.568

5.  BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Authors:  Mingzhao Xing; William H Westra; Ralph P Tufano; Yoram Cohen; Eli Rosenbaum; Kerry J Rhoden; Kathryn A Carson; Vasily Vasko; Alexandr Larin; Giovanni Tallini; Sara Tolaney; Elizabeth H Holt; Pei Hui; Christopher B Umbricht; Shehzad Basaria; Marge Ewertz; Anthony P Tufaro; Joseph A Califano; Matthew D Ringel; Martha A Zeiger; David Sidransky; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2005-09-20       Impact factor: 5.958

6.  Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors.

Authors:  I Sugitani; Y Fujimoto
Journal:  Endocr J       Date:  1999-02       Impact factor: 2.349

7.  Lymph node metastases in differentiated thyroid cancer under 2 cm.

Authors:  Rishindra M Reddy; Perry W Grigsby; Jeffrey F Moley; Bruce L Hall
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.

Authors:  Sin-Ming Chow; Stephen C K Law; John K C Chan; Siu-Kie Au; Stephen Yau; Wai-Hon Lau
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

9.  Presence of BRAF V600E in very early stages of papillary thyroid carcinoma.

Authors:  Clara Ugolini; Riccardo Giannini; Cristiana Lupi; Giuliana Salvatore; Paolo Miccoli; Agnese Proietti; Rossella Elisei; Massimo Santoro; Fulvio Basolo
Journal:  Thyroid       Date:  2007-05       Impact factor: 6.568

10.  The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

Authors:  Ilya Sedliarou; Vladimir Saenko; Dmitry Lantsov; Tatiana Rogounovitch; Hiroyuki Namba; Aleksandr Abrosimov; Eugeny Lushnikov; Atsushi Kumagai; Masahiro Nakashima; Serik Meirmanov; Mariko Mine; Tomayoshi Hayashi; Shunichi Yamashita
Journal:  Int J Oncol       Date:  2004-12       Impact factor: 5.650
View more
  16 in total

1.  Cancer: Small papillary thyroid cancers--is BRAF of prognostic value?

Authors:  Paula Soares; Manuel Sobrinho-Simões
Journal:  Nat Rev Endocrinol       Date:  2011-01       Impact factor: 43.330

Review 2.  Occult thyroid carcinoma.

Authors:  J Boucek; J Kastner; J Skrivan; E Grosso; B Gibelli; G Giugliano; J Betka
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

Review 3.  BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence.

Authors:  Agnieszka Czarniecka; Małgorzata Oczko-Wojciechowska; Marcin Barczyński
Journal:  Gland Surg       Date:  2016-10

4.  BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Fei Li; Guangqi Chen; Chunjun Sheng; Aaron M Gusdon; Yueye Huang; Zhongwei Lv; Huixiong Xu; Mingzhao Xing; Shen Qu
Journal:  Endocr Relat Cancer       Date:  2015-01-15       Impact factor: 5.678

5.  Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Authors:  Celestino P Lombardi; Rocco Bellantone; Carmela De Crea; Nunzia C Paladino; Guido Fadda; Massimo Salvatori; Marco Raffaelli
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 6.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

7.  Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer.

Authors:  Rong-Liang Shi; Ning Qu; Tian Liao; Wen-Jun Wei; Zhong-Wu Lu; Ben Ma; Yu-Long Wang; Qing-Hai Ji
Journal:  Tumour Biol       Date:  2016-01-05

Review 8.  Molecular markers of aggressiveness of thyroid cancer.

Authors:  Matthew D Ringel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-10       Impact factor: 3.243

9.  Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?

Authors:  Carmelo Nucera; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

10.  The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.

Authors:  Agnieszka Czarniecka; Monika Kowal; Dagmara Rusinek; Jolanta Krajewska; Michal Jarzab; Ewa Stobiecka; Ewa Chmielik; Ewa Zembala-Nozynska; Stanislaw Poltorak; Aleksander Sacher; Adam Maciejewski; Jadwiga Zebracka-Gala; Dariusz Lange; Malgorzata Oczko-Wojciechowska; Daria Handkiewicz-Junak; Barbara Jarzab
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.